Top Markets
Coin of the day
Biocure Technology Inc. Biocure Technology Inc.

Biocure Technology Inc.

CURE
Rankning i aktier #39915
Biocure Technology Inc., operating with its subsidiary, focuses on the creation... Biocure Technology Inc., operating with its subsidiary, focuses on the creation and market introduction of biopharmaceutical innovations, particularly those involving recombinant technologies and ranibizumab. The company's current development pipeline includes: Interferons-ß, aimed at treating multiple sclerosis. Ranibizumab, a monoclonal antibody fragment designed to address macular degeneration and a related eye condition known as macular edema. Filgrastim, which targets neutropenia – a deficiency of white blood cells that can arise from cancer, bone marrow transplants, chemotherapy, or other medical issues. Additionally, Biocure is conducting research and development into several promising areas: CAR T-cell therapy, which works by identifying and eradicating cancer cells. A vaccine against foot and mouth disease. Various products for promoting hair growth. The firm was established in 2005 and its corporate headquarters are located in Vancouver, Canada.
Aktiekurs
$0.00366968
Senast synkroniserad: 2024-07-12
Marknadsvärde
$299.46K
Förändring (1 dag)
-66.77%
Förändring (1 år)
0.00%
Land
CA
Handel Biocure Technology Inc. (CURE)

Kategori

Historik för aktiesplit för Biocure Technology Inc. (CURE)
Aktien Biocure Technology Inc. (symbol: CURE) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 14, 2026.
En CURE-aktie köpt före Aug 14, 2026 motsvarar nu 0 CURE-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE